Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ole Bonderup

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Scandinavian Journal of Gastroenterology|April 9, 2025
Iron deficiency should not be accepted in patients with inflammatory bowel disease - a Scandinavian expert opinionTrond Espen Detlie, Johan Burisch, Jørgen Jahnsen, et al.
Gastroenterology|September 10, 2018
Efficacy and Safety of Budesonide, vs Mesalazine or Placebo, as Induction Therapy for Lymphocytic ColitisStephan Miehlke, Daniela Aust, Emese Mihaly, et al.
International Journal of Colorectal Disease|September 13, 2020
Distribution of histopathological features along the colon in microscopic colitisAnne-Marie Kanstrup Fiehn, Stephan Miehlke, Daniela Aust, et al.
Journal of Crohn'S & Colitis|September 25, 2021
The Process of Developing a Disease Activity Index in Microscopic ColitisKatarina Pihl Lesnovska, Andreas Münch, Ole Bonderup, et al.
Gut|November 27, 2014
Low-dose budesonide for maintenance of clinical remission in collagenous colitis: a randomised, placebo-controlled, 12-month trialAndreas Münch, Johan Bohr, Stephan Miehlke, et al.
United European Gastroenterology Journal|February 23, 2021
European guidelines on microscopic colitis: United European Gastroenterology and European Microscopic Colitis Group statements and recommendationsStephan Miehlke, Danila Guagnozzi, Yamile Zabana, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Scandinavian Journal of Gastroenterology|April 9, 2025
Iron deficiency should not be accepted in patients with inflammatory bowel disease - a Scandinavian expert opinionTrond Espen Detlie, Johan Burisch, Jørgen Jahnsen, et al.
Gastroenterology|September 10, 2018
Efficacy and Safety of Budesonide, vs Mesalazine or Placebo, as Induction Therapy for Lymphocytic ColitisStephan Miehlke, Daniela Aust, Emese Mihaly, et al.
International Journal of Colorectal Disease|September 13, 2020
Distribution of histopathological features along the colon in microscopic colitisAnne-Marie Kanstrup Fiehn, Stephan Miehlke, Daniela Aust, et al.
Journal of Crohn'S & Colitis|September 25, 2021
The Process of Developing a Disease Activity Index in Microscopic ColitisKatarina Pihl Lesnovska, Andreas Münch, Ole Bonderup, et al.
Gut|November 27, 2014
Low-dose budesonide for maintenance of clinical remission in collagenous colitis: a randomised, placebo-controlled, 12-month trialAndreas Münch, Johan Bohr, Stephan Miehlke, et al.
United European Gastroenterology Journal|February 23, 2021
European guidelines on microscopic colitis: United European Gastroenterology and European Microscopic Colitis Group statements and recommendationsStephan Miehlke, Danila Guagnozzi, Yamile Zabana, et al.
Pageof 1